Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.66 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | IDE | P14735 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | HLCS | P50747 | 6/20 | 0.60 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4461491 | 1.00 | TDP1 (0.66) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL14247914 | 1.00 | TDP1 (0.66) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL17458950 | 1.00 | TDP1 (0.66) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL4557414 | 0.93 | TDP1 (0.72) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL7157942 | 0.92 | TDP1 (0.77) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL28163095 | 0.90 | TDP1 (0.65) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL21422293 | 0.90 | TDP1 (0.70) | TDP1PKMMEN1ABL1LMNA | |
| Biotin SCHEMBL2107780 | 0.89 | TDP1 (0.79) | TDP1PKMMEN1ABL1LMNA | |
| Biotin SCHEMBL4461484 | 0.89 | TDP1 (0.79) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL29046885 | 0.88 | HLCS (0.73) | TDP1PKMMEN1ABL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7326780-B2 | Label (fluorescence-emitting molecule, hapten-containing molecule, protein, or radioactive chemical) attached to N-(2-chloroethyl)-N-methylaminobenzylamino ligand by a spacer forming a neutralized quaternary ammonium group for covalent attachment to DNA, RNA, or siRNA | MIRUS BIO CORPORATION (US) | 2008-02-05 | — | — | US | disclosed |
| US-20060188927-A1 | Compounds and processes for single-pot attachment of a label to nucleic acid | MIRUS BIO CORPORATION | 2006-08-24 | — | — | US | disclosed |
| EP-1587815-A2 | COMPOUNDS AND PROCESSES FOR SINGLE-POT ATTACHMENT OF A LABEL TO NUCLEIC ACID | Mirus Corporation (US) | 2005-10-26 | — | — | EP | disclosed |
| WO-2004070052-A2 | COMPOUNDS AND PROCESSES FOR SINGLE-POT ATTACHMENT OF A LABEL TO NUCLEIC ACID | MIRUS CORPORATION (US) | 2004-08-19 | — | — | WO | disclosed |
| US-20040152084-A1 | Compounds and processes for single-pot attachment of a label to nucleic acid | SLATTUM PAUL M (US) | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152084-A1 | Compounds and processes for single-pot attachment of a label to nucleic acid | DNMT1, DNMT3A, PCNA | TDP1 184/4885PKM 1966/4885MEN1 1738/4885 |
| US-20060188927-A1 | Compounds and processes for single-pot attachment of a label to nucleic acid | DNMT1, DNMT3A, PCNA | TDP1 184/4885PKM 1966/4885MEN1 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.